Blood neutrophil to lymphocyte ratio (NLR) has been recognized as a biomarker for predicting the prognosis of solid tumors, and high NLR and IL-6 are significantly correlated with worse overall survival in non-metastatic CRC [163,168]. This evidence concerns the gene IL6 and colorectal carcinoma.